Premium
Contineum Therapeutics Inc (CTNM)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | Institution | 2 841 334 | 7,60% | US$ 37,96M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 2 734 836 | 7,32% | US$ 36,54M | 2026-03-31 |
| Atlas Diversified Master Fund, Ltd. | Institution | 2 417 723 | 6,47% | US$ 32,30M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 2 122 000 | 5,68% | US$ 28,35M | 2025-07-25 |
| Johnson & Johnson Innovation - JJDC, Inc. | Institution | 1 979 173 | 5,29% | US$ 26,44M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 1 839 227 | 4,92% | US$ 24,57M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 1 685 635 | 4,51% | US$ 22,52M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 535 449 | 4,11% | US$ 20,51M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 1 441 249 | 3,86% | US$ 19,26M | 2024-12-31 |
| Baker Bros. Advisors LP | Institution | 1 420 838 | 3,80% | US$ 18,98M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 1 296 012 | 3,47% | US$ 17,31M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 1 255 592 | 3,36% | US$ 16,77M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 214 173 | 3,25% | US$ 16,22M | 2026-03-31 |
| FMR LLC | Institution | 814 871 | 2,18% | US$ 10,89M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 807 874 | 2,16% | US$ 10,79M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 800 198 | 2,14% | US$ 10,69M | 2026-03-31 |
| Longaeva Partners L.P. | Institution | 732 088 | 1,96% | US$ 9,78M | 2026-03-31 |
| Sectoral Asset Management Inc. | Institution | 727 587 | 1,95% | US$ 9,72M | 2026-03-31 |
| Hillhouse Investment Management, Ltd. | Institution | 669 337 | 1,79% | US$ 8,94M | 2026-03-31 |
| BlackRock, Inc. | Institution | 669 123 | 1,79% | US$ 8,94M | 2026-03-31 |
| Red Tree Venture Capital | Institution | 638 158 | 1,71% | US$ 8,53M | 2026-03-31 |
| Versant Venture Management, LLC | Institution | 542 628 | 1,45% | US$ 7,25M | 2026-03-31 |
| Jones Hill Capital LP | Institution | 513 053 | 1,37% | US$ 6,85M | 2026-03-31 |
| Boxer Capital Management, LLC | Institution | 494 000 | 1,32% | US$ 6,60M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 371 636 | 0,99% | US$ 4,97M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 350 200 | 0,94% | US$ 4,68M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 307 108 | 0,82% | US$ 4,10M | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 301 729 | 0,81% | US$ 4,03M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 282 038 | 0,75% | US$ 3,77M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 276 661 | 0,74% | US$ 3,70M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 232 534 | 0,62% | US$ 3,11M | 2026-03-31 |
| UBS Asset Management AG | Institution | 230 409 | 0,62% | US$ 3,08M | 2026-03-31 |
| Marshall Wace LLP | Institution | 226 302 | 0,61% | US$ 3,02M | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 222 329 | 0,59% | US$ 2,97M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 173 475 | 0,46% | US$ 2,32M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 153 924 | 0,41% | US$ 2,06M | 2026-03-31 |
| Dr. Daniel Lorrain | Initiés | 149 482 | 0,40% | US$ 2,00M | 2026-06-01 |
| Casdin Capital, LLC | Institution | 148 333 | 0,40% | US$ 1,98M | 2026-03-31 |
| Eversept Partners, L.P. | Institution | 146 411 | 0,39% | US$ 1,96M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 144 009 | 0,39% | US$ 1,92M | 2026-03-31 |
| Ishara Investments, L.P. | Institution | 142 000 | 0,38% | US$ 1,90M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
